J&J | JNJ - Capital Ordinário





Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Abbott USD 1.74B 2.94M 2026-03
Amgen USD 540M 1000K 2026-03
AstraZeneca USD 1.55B 73K 2026-03
Baxter International USD 516.45M 2.17M 2026-03
Bayer EUR 982.42M 0 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Biogen USD 146.7M 200K 2025-09
Boston Scientific USD 1.48B 2.66M 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
CONMED USD 30.97M 16K 2025-12
Cooper Companies USD 195.11M 14K 2026-03
Dexcom USD 385.9M 1.1M 2026-03
Edwards Lifesciences USD 580.7M 0 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-03
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Globus Medical USD 135.06M 449K 2025-12
Insulet USD 69.26M 1.08M 2026-03
Integra LifeSciences USD 77.82M 69K 2026-03
Intuitive Surgical USD 354.16M 1.01M 2026-06
J&J USD 2.41B 1.35M 2026-03
Medtronic USD 1.28B 1.38M 2025-12
Merck USD 2.47B 12.72M 2025-12
Merit Medical Systems USD 59.65M 231K 2026-03
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.7B 13M 2026-03
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
Stryker USD 382.98M 584K 2026-03
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teva Pharmaceutical Industries USD 1.16B 16.72M 2026-03
Vertex Pharmaceuticals USD 254.2M 200K 2026-03
Zimmer Biomet Holdings USD 195.5M 2.68M 2026-03
Zoetis USD 420.35M 4.58M 2026-03